Short Squeeze - CMMBIdea for Chemomab Therapeutics Ltd.:
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.
- Bottom of Risk Range:
- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. www.marketbeat.com
- Good short squeeze material.
- Non Optionable.
Bought the shares $16.69
Expect share dilution $40-$50
GLHF
- DPT
